An extended cost-effectiveness analysis of decentralised TB diagnostic testing with Molbio Truenat MTB/RIF versus hub-and-spoke GeneXpert MTB/RIF in Mozambique and Tanzania

Background In low- and middle-income countries (LMICs), tuberculosis (TB) regained its status as the leading cause of death from a single infectious agent in 2023, surpassing COVID-19. Rapid and accurate diagnosis is critical, with decentralised diagnostic strategies offering a promising solution. A...

Cijeli opis

Bibliografski detalji

Glavni autori:	Adam Penn-Nicholson, Jerry Hella, Manuela De Allegri, Claudia M Denkinger, David Dowdy, Lelisa Fekadu Assebe, Morten Ruhwald, Saima Bashir, António Machiana, Leyla Larsson, Délio Elísio, Akash Malhotra, Anange Lwilla, Vinzeigh Leukes, Neenah Young, Mikaela Watson
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2025-11-01
Serija:	BMJ Global Health
Online pristup:	https://gh.bmj.com/content/10/11/e020117.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!